KR100334139B1 - 항산화 효과를 갖는 아스코르브산 유도체의 제조방법 - Google Patents
항산화 효과를 갖는 아스코르브산 유도체의 제조방법 Download PDFInfo
- Publication number
- KR100334139B1 KR100334139B1 KR1019990008784A KR19990008784A KR100334139B1 KR 100334139 B1 KR100334139 B1 KR 100334139B1 KR 1019990008784 A KR1019990008784 A KR 1019990008784A KR 19990008784 A KR19990008784 A KR 19990008784A KR 100334139 B1 KR100334139 B1 KR 100334139B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- ascorbic acid
- group
- represented
- hydrogen atom
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 125000003289 ascorbyl group Polymers [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 title claims abstract description 13
- 150000000996 L-ascorbic acids Polymers 0.000 title description 28
- 239000003963 antioxidant agent Substances 0.000 title description 5
- 235000006708 antioxidants Nutrition 0.000 title description 5
- 238000002360 preparation method Methods 0.000 title description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 49
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 26
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 12
- 239000003377 acid catalyst Substances 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 150000002334 glycols Chemical class 0.000 claims abstract description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 5
- 125000005843 halogen group Chemical group 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims abstract description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- 238000010531 catalytic reduction reaction Methods 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 239000007864 aqueous solution Substances 0.000 abstract description 6
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 66
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 229960005070 ascorbic acid Drugs 0.000 description 32
- 235000010323 ascorbic acid Nutrition 0.000 description 31
- 239000011668 ascorbic acid Substances 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 27
- 239000011718 vitamin C Substances 0.000 description 18
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- -1 feed Substances 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 8
- 230000002292 Radical scavenging effect Effects 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N ethylene glycol dimethyl ether Natural products COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 238000010934 O-alkylation reaction Methods 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cosmetics (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
아스코르브산 유도체 | 회수율(%) | |||
pH 4 | pH 5 | pH 6 | pH 7 | |
3-O-PEG350-비타민 C | 91.4 | 89.2 | 85.4 | 63.5 |
3-O-PEG550-비타민 C | 78.5 | 70.8 | 61.3 | 42.5 |
2-O-PEG350-비타민 C | 90.8 | 89.5 | 84.3 | 59.8 |
2-O-PEG550-비타민 C | 91.1 | 89.9 | 85.7 | 62.4 |
비타민 C(Fluka사 제품) | 38.2 | 27.5 | - | - |
아스코르브산 유도체의 라디칼 소거작용(단위: ×10-5M) | ||
30분 반응 | 24시간 반응 | |
3-O-PEG350-비타민 C | 78.7 | 5.9 |
3-O-PEG550-비타민 C | 423.6 | 112.9 |
2-O-PEG350-비타민 C | 7.9 | 5.9 |
2-O-PEG550-비타민 C | 7.9 | 4.2 |
3-O-Et-비타민 C | 9.8 | 9.8 |
비타민 C(fluka사 제품) | 3.4 | 3.4 |
Claims (8)
- 다음 화학식 4로 표시되는 화합물을 염기 존재하에 용매 중에서 다음 화학식 5로 표시되는 폴리에틸렌 글리콜 유도체와 반응시키는 단계; 및산촉매로 가수분해시키는 단계로 이루어진 다음 화학식 1로 표시되는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.화학식 1상기 식에서, R1및 R2는 서로 다른 것으로서, 수소원자 또는 (CH2CH2O)nOR3(여기서, n은 2∼400의 정수이고, R3는 탄소원자수 1∼10의 저급 알킬기이다)이다.화학식 4상기 식에서, R4및 R5는 서로 같거나 다른 것으로서, 각각 수소원자, 메틸기 또는 에틸기, 또는 R4와 R5가 결합하여 -(CH2)m-(여기서, m은 4 또는 5이다)이고,R6는 수소원자, 벤질기 또는 파라메톡시벤질기이다.화학식 5상기 식에서, R7은 탄소원자수 1∼10의 저급 알킬기이며, X는 할로겐 원자 또는 설포네이트기 이다.
- 제 1 항에 있어서, 염기로는 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 탄산세슘 및 수소화나트륨 중에서 선택된 1종 이상의 금속염을 사용하는 것을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.
- 제 1 항에 있어서, 용매로는 디메틸포름아마이드, 디메틸설폭사이드, 헥사메틸포스포르아마이드, N-메틸피롤리돈, 피롤리돈 및 디메틸아세트아마이드로 이루어진 군으로부터 선택하여 사용하는 것을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.
- 제 1 항에 있어서, 산촉매로는 염산, 황산, 파라톨루엔술폰산, 켐퍼닐술폰산 및 아세트산으로 이루어진 군으로부터 선택하여 사용하는 것을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.
- 제 1 항에 있어서, 산촉매로 가수분해시킨 전 추가로 촉매환원 반응 단계를 수행하는 것을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.
- 제 5 항에 있어서, 촉매환원 반응시 촉매로는 팔라듐, 팔라듐-탄소, 백금 블랙 및 이산화백금으로 이루어진 군으로부터 선택하여 사용하는 것을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.
- 제 1 항에 있어서, 화학식 1로 표시되는 아스코르브산 유도체는 다음 화학식 2로 표시되는 화합물인 것임을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.화학식 2상기 식에서, PEG는 (CH2CH2O)nOR3(여기서, n, R3는 상기와 같다)이다
- 제 1 항에 있어서, 화학식 1로 표시되는 화합물은 다음 화학식 3으로 표시되는 화합물인 것임을 특징으로 하는 항산화 효과를 갖는 아스코르브산 유도체의 제조방법.화학식 3상기 식에서, PEG는 상기한 바와 같다.
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990008784A KR100334139B1 (ko) | 1999-03-16 | 1999-03-16 | 항산화 효과를 갖는 아스코르브산 유도체의 제조방법 |
NZ506842A NZ506842A (en) | 1998-03-27 | 1999-03-27 | Antioxidant polyethoxylated ascorbic acid derivatives and process for preparation |
PCT/KR1999/000148 WO1999050258A1 (en) | 1998-03-27 | 1999-03-27 | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
DE69909455T DE69909455T2 (de) | 1998-03-27 | 1999-03-27 | Polyethoxylierte ascorbinsäurederivate als neue antioxidantien und verfahren zu ihrer herstellung |
CN99804461A CN1295567A (zh) | 1998-03-27 | 1999-03-27 | 作为新型抗氧剂的聚乙氧基化抗坏血酸衍生物及其制备方法 |
JP2000541162A JP3440263B2 (ja) | 1998-03-27 | 1999-03-27 | 新規アスコルビン酸誘導体及びその調製方法 |
BR9909168-2A BR9909168A (pt) | 1998-03-27 | 1999-03-27 | Derivados de ácido ascórbico polietoxilados como anti-oxidantes e processo para preparação dos mesmo |
EP99909388A EP1066277B1 (en) | 1998-03-27 | 1999-03-27 | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
AU28595/99A AU741933B2 (en) | 1998-03-27 | 1999-03-27 | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
CA002324306A CA2324306C (en) | 1998-03-27 | 1999-03-27 | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
AT99909388T ATE244707T1 (de) | 1998-03-27 | 1999-03-27 | Polyethoxylierte ascorbinsäurederivate als neue antioxidantien und verfahren zu ihrer herstellung |
US09/671,094 US6444144B1 (en) | 1998-03-27 | 2000-09-27 | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990008784A KR100334139B1 (ko) | 1999-03-16 | 1999-03-16 | 항산화 효과를 갖는 아스코르브산 유도체의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000060467A KR20000060467A (ko) | 2000-10-16 |
KR100334139B1 true KR100334139B1 (ko) | 2002-04-25 |
Family
ID=19576689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990008784A KR100334139B1 (ko) | 1998-03-27 | 1999-03-16 | 항산화 효과를 갖는 아스코르브산 유도체의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100334139B1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010088633A (ko) * | 2001-08-14 | 2001-09-28 | 김진경 | 비타민c를 혼합한 향액의 이용 방법 |
KR100450274B1 (ko) * | 2001-07-30 | 2004-09-30 | 주식회사 엘지생명과학 | 폴리에톡실화 아스코르브산 유도체를 함유하는 동물용사료첨가제 조성물 |
KR100459679B1 (ko) * | 2003-04-30 | 2004-12-03 | 주식회사 펩트론 | 펩타이드가 결합된 비타민 씨 유도체, 이의 제조방법 및이를 포함하는 조성물 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100440191B1 (ko) * | 2001-08-23 | 2004-07-12 | 박관화 | 항산화 효과 및 높은 안정성을 갖는 아스코르브산 유도체및 그것의 제조방법 |
KR100440190B1 (ko) * | 2001-08-23 | 2004-07-12 | 박관화 | 아카비오신-글루코실 아스코르베이트 및 그의 제조방법 |
KR100817191B1 (ko) * | 2001-09-27 | 2008-03-27 | 주식회사 엘지생활건강 | Tat 펩타이드가 결합된 아스코르브산 유도체, 그의제조방법 및 이를 포함하는 피부 미백용 화장료 조성물 |
-
1999
- 1999-03-16 KR KR1019990008784A patent/KR100334139B1/ko not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100450274B1 (ko) * | 2001-07-30 | 2004-09-30 | 주식회사 엘지생명과학 | 폴리에톡실화 아스코르브산 유도체를 함유하는 동물용사료첨가제 조성물 |
KR20010088633A (ko) * | 2001-08-14 | 2001-09-28 | 김진경 | 비타민c를 혼합한 향액의 이용 방법 |
KR100459679B1 (ko) * | 2003-04-30 | 2004-12-03 | 주식회사 펩트론 | 펩타이드가 결합된 비타민 씨 유도체, 이의 제조방법 및이를 포함하는 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20000060467A (ko) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU741933B2 (en) | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof | |
KR100334139B1 (ko) | 항산화 효과를 갖는 아스코르브산 유도체의 제조방법 | |
EP3154669B1 (fr) | Compositions d'éthers mono-alkyliques de monoanhydro-hexitols, procédés de préparation et leur utilisation | |
RAUT et al. | Synthesis of certain chalcones and 3-hydroxychromones | |
JP2008266172A (ja) | 3−o−アルキル−5,6−o−(1−メチルエチリデン)−l−アスコルビン酸の製造方法および5,6−o−(1−メチルエチリデン)−l−アスコルビン酸の製造方法 | |
JP3112341B2 (ja) | ビタミンc及びビタミンeを含む結合体ならびに製造方法 | |
EP0685473B1 (fr) | Composés benzohétérocycliques, en tant qu'antioxydants | |
KR100548989B1 (ko) | 3-o-치환된-아스코르빈산의 제조방법 | |
EP2331549B1 (fr) | Procede de preparation du 1,6:2,3-dianhydro-beta-d-mannopyranose | |
CN110563670A (zh) | 一种含硫哌嗪衍生物及其应用 | |
JPH0730066B2 (ja) | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 | |
MXPA00009417A (en) | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof | |
JP4269462B2 (ja) | チオフェン−3−カルボキサルデヒドの製造方法 | |
JP4134290B2 (ja) | ポリフェノール誘導体、その製造方法、抗酸化剤、および発がん予防剤 | |
CN113999115A (zh) | 一种四氢姜黄素肉桂酸二酯的合成方法 | |
JP3423430B2 (ja) | アスコルビン酸−コウジ酸結合体ならびにその製造方法 | |
CN1319939C (zh) | 3,4-二羟基-2-氨基丁酸衍生物的制备方法 | |
AU2004202747B2 (en) | Compositions and therapeutic methods involving isoflavones and analogues thereof | |
US5200531A (en) | Process for the production of threo-4-alkoxy-5- (arylhydroxymethyl)-2(5h)-furanones | |
JP3973398B2 (ja) | 熱的に安定なフェルラ酸誘導体、その製造方法およびそれを有効成分として含有する紫外線吸収剤 | |
JPH078827B2 (ja) | α,β‐不飽和アルデヒドの製造方法 | |
JPH0570629B2 (ko) | ||
JPH04145036A (ja) | 新規フェノール誘導体 | |
JPH0531557B2 (ko) | ||
JPS6332057B2 (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140311 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20150316 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20170306 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20180403 Year of fee payment: 17 |
|
EXPY | Expiration of term |